Adelaide Fernandes received her degree in Pharmaceutical Sciences in 2002. She performs neuroscience research since 2002. Her PhD studies focused on glia reactivity during neonatal development were performed at the Faculty of Pharmacy of the University of Lisbon (FFULisboa), having received her PhD in 2006, from the University of Lisbon. From 2006 to 2010 she developed post-doctoral studies focused on changed on neuronal development and myelination during early postnatal conditions, at Research Institute for Medicines (iMed.Ulisboa) and Department of Neuroscience, University of Minneapolis. She is Assistant Professor at FFUlisboa since 2011. Adelaide research focuses on neuron-glial interplay during neurodevelopment and neurodegenerative disorders. Adelaide explored the impact of neurodevelopmental disorders (e.g. jaundice, sepsis) on astrogliosis, neurodegeneration and recently on oligodendrogenesis and myelination. Presently, Adelaide addresses the relevance of microglia in degenerative disorders by exploring microRNA-dependent microglia phenotype switch on Alzheimer’s Disease and the role of neuroinflammation and immune cell recruitment on demyelination/remyelination during Multiple Sclerosis. Her work granted her a Medal of Honour L’Óreal for Women in Science – L’Óreal/UNESCO/FCT in 2011 and an Innovation Research Grant from Portuguese Pharmaceutical Society in 2013, in parallel with funding from other research projects and procurement agreements.